1. Home
  2. STVN vs OLED Comparison

STVN vs OLED Comparison

Compare STVN & OLED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • OLED
  • Stock Information
  • Founded
  • STVN 1949
  • OLED 1985
  • Country
  • STVN Italy
  • OLED United States
  • Employees
  • STVN N/A
  • OLED N/A
  • Industry
  • STVN Containers/Packaging
  • OLED Semiconductors
  • Sector
  • STVN Consumer Discretionary
  • OLED Technology
  • Exchange
  • STVN Nasdaq
  • OLED Nasdaq
  • Market Cap
  • STVN 6.2B
  • OLED 7.4B
  • IPO Year
  • STVN 2021
  • OLED 1992
  • Fundamental
  • Price
  • STVN $22.96
  • OLED $138.05
  • Analyst Decision
  • STVN Buy
  • OLED Strong Buy
  • Analyst Count
  • STVN 4
  • OLED 7
  • Target Price
  • STVN $25.13
  • OLED $190.43
  • AVG Volume (30 Days)
  • STVN 341.4K
  • OLED 503.5K
  • Earning Date
  • STVN 08-05-2025
  • OLED 10-29-2025
  • Dividend Yield
  • STVN 0.27%
  • OLED 1.30%
  • EPS Growth
  • STVN 6.78
  • OLED 9.88
  • EPS
  • STVN 0.57
  • OLED 5.12
  • Revenue
  • STVN $1,344,798,591.00
  • OLED $661,991,000.00
  • Revenue This Year
  • STVN $8.24
  • OLED $6.28
  • Revenue Next Year
  • STVN $10.38
  • OLED $10.49
  • P/E Ratio
  • STVN $40.05
  • OLED $27.07
  • Revenue Growth
  • STVN 5.28
  • OLED 6.23
  • 52 Week Low
  • STVN $17.12
  • OLED $103.70
  • 52 Week High
  • STVN $28.00
  • OLED $215.90
  • Technical
  • Relative Strength Index (RSI)
  • STVN 47.98
  • OLED 41.45
  • Support Level
  • STVN $21.51
  • OLED $138.85
  • Resistance Level
  • STVN $23.72
  • OLED $145.02
  • Average True Range (ATR)
  • STVN 0.84
  • OLED 3.14
  • MACD
  • STVN 0.09
  • OLED 0.34
  • Stochastic Oscillator
  • STVN 65.77
  • OLED 32.77

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

Share on Social Networks: